| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.62 | 0.02 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |